Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
The Journal of Clinical Investigation|March 15, 2022
Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotypeYounglang Lee, Alex W Wessel, Jiazhi Xu, et al.
Cellular and Molecular Bioengineering|May 20, 2020
Evaluation of the Antihemostatic and Antithrombotic Effects of Lowering Coagulation Factor VII Levels in a Non-human PrimateMichael Wallisch, Sven R Olson, Jeffrey Crosby, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primatesMichael Wallisch, Christina U Lorentz, Hari H S Lakshmanan, et al.
Metabolic Brain Disease|June 21, 2023
Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in miceTia C L Kohs, Meghan E Fallon, Ethan C Oseas, et al.
American Journal of Physiology. Cell Physiology|June 21, 2013
The PAK system links Rho GTPase signaling to thrombin-mediated platelet activationJoseph E Aslan, Sandra M Baker, Cassandra P Loren, et al.
Scientific Reports|February 9, 2022
Irreversible alteration of extracellular vesicle and cell-free messenger RNA profiles in human plasma associated with blood processing and storageHyun Ji Kim, Matthew J Rames, Samuel Tassi Yunga, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 6, 2023
Factor XI Inhibition With Heparin Reduces Clot Formation in Simulated Pediatric Extracorporeal Membrane OxygenationAndrew D Meyer, Catherine R Thorpe, Tamara Fraker, et al.
Platelets|June 7, 2021
Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet functionIván Parra-Izquierdo, Alexander R Melrose, Jiaqing Pang, et al.
Blood Advances|January 27, 2022
Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domainsAleksandr Shamanaev, Ivan Ivanov, Mao-Fu Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2009
Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanismMeredith W Miller, Sandeep Basra, Daniel W Kulp, et al.
Pageof 23